Skip to main content
. 2022 May 4;261:127055. doi: 10.1016/j.micres.2022.127055

Fig. 3.

Fig. 3

Association of microbial communities with COVID-19 conditions and co-morbidities. (a) Non-metric multidimensional scaling showed difference in the microbial community composition between symptomatic and asymptomatic infected patients. (b) Identification of differentially-abundant genera between symptomatic and asymptomatic infected patients. (c) Microbial community composition at genera-level between infected patients with or without comorbidities. (d) Identification of differentially-abundant genera in infected patients with or without comorbidities.